메뉴 건너뛰기




Volumn 29, Issue 1, 2009, Pages 7-16

Blood coagulation dynamics in haemostasis

Author keywords

Blood coagulation; Haemostasis; Numerical models; Phenotype variability; Thrombin

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8A; BLOOD CLOTTING FACTOR 9A; PROTEIN C; PROTEOME; PROTHROMBIN; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

EID: 59649112382     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616932     Document Type: Review
Times cited : (51)

References (33)
  • 1
    • 0037166290 scopus 로고    scopus 로고
    • A model for the stoichiometric regulation of blood coagulation
    • Hockin MF, Jones KC, Everse SJ, Mann KG. A model for the stoichiometric regulation of blood coagulation. J Biol Chem 2002; 277: 18322-18333.
    • (2002) J Biol Chem , vol.277 , pp. 18322-18333
    • Hockin, M.F.1    Jones, K.C.2    Everse, S.J.3    Mann, K.G.4
  • 2
    • 0028064839 scopus 로고
    • A model for the tissue factor pathway to thrombin. I. An empirical study
    • Lawson JH, Kalafatis M, Stram S, Mann KG. A model for the tissue factor pathway to thrombin. I. An empirical study. J Biol Chem 1994; 269: 23357-23366.
    • (1994) J Biol Chem , vol.269 , pp. 23357-23366
    • Lawson, J.H.1    Kalafatis, M.2    Stram, S.3    Mann, K.G.4
  • 3
    • 0031058039 scopus 로고    scopus 로고
    • Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin- III, and heparin cofactor-II
    • Van't Veer C, Mann KG. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin- III, and heparin cofactor-II. J Biol Chem 1997; 272: 4367-4377.
    • (1997) J Biol Chem , vol.272 , pp. 4367-4377
    • Van't Veer, C.1    Mann, K.G.2
  • 4
    • 1842293383 scopus 로고    scopus 로고
    • Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases
    • Butenas S, van't Veer C, Mann KG. Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases. J Biol Chem 1997; 272: 21527-21533.
    • (1997) J Biol Chem , vol.272 , pp. 21527-21533
    • Butenas, S.1    van't Veer, C.2    Mann, K.G.3
  • 5
    • 0027936105 scopus 로고
    • A model for the tissue factor pathway to thrombin. II. A mathematical simulation
    • Jones KC, Mann KG. A model for the tissue factor pathway to thrombin. II. A mathematical simulation. J Biol Chem 1994; 269: 23367-23373.
    • (1994) J Biol Chem , vol.269 , pp. 23367-23373
    • Jones, K.C.1    Mann, K.G.2
  • 6
    • 0029858330 scopus 로고    scopus 로고
    • Blood clotting in minimally altered whole blood
    • Rand MD, Lock JB, van't Veer C et al. Blood clotting in minimally altered whole blood. Blood 1996; 88: 3432-3445.
    • (1996) Blood , vol.88 , pp. 3432-3445
    • Rand, M.D.1    Lock, J.B.2    van't Veer, C.3
  • 7
    • 0036660207 scopus 로고    scopus 로고
    • Thrombin functions during tissue factor-induced blood coagulation
    • Brummel KE, Paradis SG, Butenas S, Mann KG. Thrombin functions during tissue factor-induced blood coagulation. Blood 2002; 100: 148-152.
    • (2002) Blood , vol.100 , pp. 148-152
    • Brummel, K.E.1    Paradis, S.G.2    Butenas, S.3    Mann, K.G.4
  • 8
    • 2642651894 scopus 로고    scopus 로고
    • Blood coagulation in hemophilia A and hemophilia C
    • Cawthern KM, van't Veer C, Lock JB et al. Blood coagulation in hemophilia A and hemophilia C. Blood 1998; 91: 4581-4592.
    • (1998) Blood , vol.91 , pp. 4581-4592
    • Cawthern, K.M.1    van't Veer, C.2    Lock, J.B.3
  • 9
    • 0035871811 scopus 로고    scopus 로고
    • Antiplatelet agents in tissue factor-induced blood coagulation
    • Butenas S, Cawthern KM, van't Veer C et al. Antiplatelet agents in tissue factor-induced blood coagulation. Blood 2001; 97: 2314-2322.
    • (2001) Blood , vol.97 , pp. 2314-2322
    • Butenas, S.1    Cawthern, K.M.2    van't Veer, C.3
  • 10
    • 13244277499 scopus 로고    scopus 로고
    • Factor VIIa replacement therapy in factor VII deficiency
    • Brummel-Ziedins K, Rivard GE, Pouliot RL et al. Factor VIIa replacement therapy in factor VII deficiency. J Thromb Haemost 2004; 2: 1735-1744.
    • (2004) J Thromb Haemost , vol.2 , pp. 1735-1744
    • Brummel-Ziedins, K.1    Rivard, G.E.2    Pouliot, R.L.3
  • 11
    • 0035826856 scopus 로고    scopus 로고
    • Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation
    • Undas A, Brummel KE, Musial J et al. Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation. Circulation 2001; 103: 2248-2253.
    • (2001) Circulation , vol.103 , pp. 2248-2253
    • Undas, A.1    Brummel, K.E.2    Musial, J.3
  • 12
    • 0035889148 scopus 로고    scopus 로고
    • Blood coagulation at the site of microvascular injury: Effects of low- dose aspirin
    • Undas A, Brummel K, Musial J et al. Blood coagulation at the site of microvascular injury: effects of low- dose aspirin. Blood 2001; 98: 2423-2431.
    • (2001) Blood , vol.98 , pp. 2423-2431
    • Undas, A.1    Brummel, K.2    Musial, J.3
  • 13
    • 30644464285 scopus 로고    scopus 로고
    • Factor XIII Val34Leu polymorphism and gamma-chain cross-linking at the site of microvascular injury in healthy and coumadin-treated subjects
    • Undas A, Brzezinska-Kolarz B, Brummel-Ziedins K et al. Factor XIII Val34Leu polymorphism and gamma-chain cross-linking at the site of microvascular injury in healthy and coumadin-treated subjects. J Thromb Haemost 2005; 3: 2015-2021.
    • (2005) J Thromb Haemost , vol.3 , pp. 2015-2021
    • Undas, A.1    Brzezinska-Kolarz, B.2    Brummel-Ziedins, K.3
  • 14
    • 59649095733 scopus 로고    scopus 로고
    • Undas A, Szuldrzynski K, Brummel-Ziedins KE et al. Systemic blood coagulation activation in acute coronary syndromes. Blood 2008; [Epub ahead of print].
    • Undas A, Szuldrzynski K, Brummel-Ziedins KE et al. Systemic blood coagulation activation in acute coronary syndromes. Blood 2008; [Epub ahead of print].
  • 15
    • 0025311157 scopus 로고
    • Surface-dependent reactions of the vitamin K-dependent enzyme complexes
    • Mann KG, Nesheim ME, Church WR et al. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 1990; 76: 1-16.
    • (1990) Blood , vol.76 , pp. 1-16
    • Mann, K.G.1    Nesheim, M.E.2    Church, W.R.3
  • 16
    • 0018627168 scopus 로고
    • Kinetics of the tissue factor-dependent activation of coagulation Factors IX and X in a bovine plasma system
    • Jesty J, Silverberg SA. Kinetics of the tissue factor-dependent activation of coagulation Factors IX and X in a bovine plasma system. J Biol Chem 1979; 254: 12337-12345.
    • (1979) J Biol Chem , vol.254 , pp. 12337-12345
    • Jesty, J.1    Silverberg, S.A.2
  • 17
    • 0017639138 scopus 로고
    • Activation of factor IX by the reaction product of tissue factor and factor VII: Additional pathway for initiating blood coagulation
    • Osterud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1977; 74: 5260-5264.
    • (1977) Proc Natl Acad Sci USA , vol.74 , pp. 5260-5264
    • Osterud, B.1    Rapaport, S.I.2
  • 18
    • 2342420637 scopus 로고    scopus 로고
    • Formation of factors IXa and Xa by the extrinsic pathway: Differential regulation by tissue factor pathway inhibitor and antithrombin III
    • Lu G, Broze GJ Jr, Krishnaswamy S. Formation of factors IXa and Xa by the extrinsic pathway: differential regulation by tissue factor pathway inhibitor and antithrombin III. J Biol Chem 2004; 279: 17241-17249.
    • (2004) J Biol Chem , vol.279 , pp. 17241-17249
    • Lu, G.1    Broze Jr, G.J.2    Krishnaswamy, S.3
  • 19
    • 2442437854 scopus 로고    scopus 로고
    • The factor V activation paradox
    • Orfeo T, Brufatto N, Nesheim ME et al. The factor V activation paradox. J Biol Chem 2004; 279: 19580-19591.
    • (2004) J Biol Chem , vol.279 , pp. 19580-19591
    • Orfeo, T.1    Brufatto, N.2    Nesheim, M.E.3
  • 20
    • 0018622772 scopus 로고
    • The contribution of bovine factor V and factor Va to the activity of prothrombinase
    • Nesheim ME, Taswell JB, Mann KG. The contribution of bovine factor V and factor Va to the activity of prothrombinase. J Biol Chem 1979; 254: 10952-10962.
    • (1979) J Biol Chem , vol.254 , pp. 10952-10962
    • Nesheim, M.E.1    Taswell, J.B.2    Mann, K.G.3
  • 21
    • 0019831499 scopus 로고
    • The role of phospholipid and factor VIIIa in the activation of bovine factor X
    • Van Dieijen G, Tans G, Rosing J, Hemker HC. The role of phospholipid and factor VIIIa in the activation of bovine factor X. J Biol Chem 1981; 256: 3433-3442.
    • (1981) J Biol Chem , vol.256 , pp. 3433-3442
    • Van Dieijen, G.1    Tans, G.2    Rosing, J.3    Hemker, H.C.4
  • 22
    • 0025010978 scopus 로고
    • Proteolytic activation of human factors IX and X by recombinant human factor VIIa: Effects of calcium, phospholipids, and tissue factor
    • Komiyama Y, Pedersen AH, Kisiel W. Proteolytic activation of human factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids, and tissue factor. Biochemistry 1990; 29: 9418-9425.
    • (1990) Biochemistry , vol.29 , pp. 9418-9425
    • Komiyama, Y.1    Pedersen, A.H.2    Kisiel, W.3
  • 23
    • 0034651933 scopus 로고    scopus 로고
    • Inhibition of thrombin generation by the zymogen factor VII: Implications for the treatment of hemophilia A by factor VIIa
    • Van't Veer C, Golden NJ, Mann KG. Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa. Blood 2000; 95: 1330-1335.
    • (2000) Blood , vol.95 , pp. 1330-1335
    • Van't Veer, C.1    Golden, N.J.2    Mann, K.G.3
  • 24
    • 44349167737 scopus 로고    scopus 로고
    • The nature of the stable blood clot procoagulant activities
    • Orfeo T, Brummel-Ziedins KE, Gissel M et al. The nature of the stable blood clot procoagulant activities. J Biol Chem 2008; 283: 9776-9786.
    • (2008) J Biol Chem , vol.283 , pp. 9776-9786
    • Orfeo, T.1    Brummel-Ziedins, K.E.2    Gissel, M.3
  • 25
    • 59649092367 scopus 로고    scopus 로고
    • Brummel-Ziedins K, Orfeo T, Jenny NS et al. Blood coagulation and fibrinolysis. In: Greer JP, Foerster J, Lukens J et al. (eds). Wintrobe's Clinical Hematology. Philidelphia: Lippencott Williams & Wilkins 2003; 677-774.
    • Brummel-Ziedins K, Orfeo T, Jenny NS et al. Blood coagulation and fibrinolysis. In: Greer JP, Foerster J, Lukens J et al. (eds). Wintrobe's Clinical Hematology. Philidelphia: Lippencott Williams & Wilkins 2003; 677-774.
  • 26
    • 0037422559 scopus 로고    scopus 로고
    • Aspirin alters the cardioprotective effects of the factor XIII Val34Leu polymorphism
    • Undas A, Sydor WJ, Brummel K et al. Aspirin alters the cardioprotective effects of the factor XIII Val34Leu polymorphism. Circulation 2003; 107: 17-20.
    • (2003) Circulation , vol.107 , pp. 17-20
    • Undas, A.1    Sydor, W.J.2    Brummel, K.3
  • 27
    • 0035960620 scopus 로고    scopus 로고
    • Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury
    • Undas A, Brummel K, Musial J et al. Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury. Circulation 2001; 104: 2666-2672.
    • (2001) Circulation , vol.104 , pp. 2666-2672
    • Undas, A.1    Brummel, K.2    Musial, J.3
  • 28
    • 0033214353 scopus 로고    scopus 로고
    • Normal thrombin generation
    • Butenas S, van't Veer C, Mann KG. "Normal" thrombin generation. Blood 1999; 94: 2169-2178.
    • (1999) Blood , vol.94 , pp. 2169-2178
    • Butenas, S.1    van't Veer, C.2    Mann, K.G.3
  • 29
    • 13244289812 scopus 로고    scopus 로고
    • Does the genotype predict the phenotype? Evaluations of the hemostatic proteome
    • Mann KG, Brummel-Ziedins K, Undas A, Butenas S. Does the genotype predict the phenotype? Evaluations of the hemostatic proteome. J Thromb Haemost 2004; 2: 1727-1734.
    • (2004) J Thromb Haemost , vol.2 , pp. 1727-1734
    • Mann, K.G.1    Brummel-Ziedins, K.2    Undas, A.3    Butenas, S.4
  • 30
    • 25144463563 scopus 로고    scopus 로고
    • The plasma hemostatic proteome: Thrombin generation in healthy individuals
    • Brummel-Ziedins K, Vossen CY, Rosendaal FR et al. The plasma hemostatic proteome: thrombin generation in healthy individuals. J Thromb Haemost 2005; 3: 1472-1481.
    • (2005) J Thromb Haemost , vol.3 , pp. 1472-1481
    • Brummel-Ziedins, K.1    Vossen, C.Y.2    Rosendaal, F.R.3
  • 31
  • 32
    • 37549018513 scopus 로고    scopus 로고
    • Thrombin generation in acute coronary syndrome and stable coronary artery disease: Dependence on plasma factor composition
    • Brummel-Ziedins K, Undas A, Orfeo T et al. Thrombin generation in acute coronary syndrome and stable coronary artery disease: dependence on plasma factor composition. J Thromb Haemost 2008; 6: 104-110.
    • (2008) J Thromb Haemost , vol.6 , pp. 104-110
    • Brummel-Ziedins, K.1    Undas, A.2    Orfeo, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.